Overview

POC Study to Evaluate the Efficacy and Safety of ESK-001 in Patients With Active Intermediate, Posterior, or Pan NIU

Status:
Active, not recruiting
Trial end date:
2025-04-30
Target enrollment:
Participant gender:
Summary
This is a multi-center, randomized, double-masked, proof-of-concept study in patients with Active Noninfectious Intermediate, Posterior, or Panuveitis.
Phase:
Phase 2
Details
Lead Sponsor:
Alumis Inc